Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2014, Article ID 864317, 6 pages
http://dx.doi.org/10.1155/2014/864317
Research Article

Usefulness of Lipid Apheresis in the Treatment of Familial Hypercholesterolemia

1Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, 920 E 28th Street, Minneapolis, MN 55407, USA
2Minneapolis Heart Institute at Abbott Northwestern Hospital, 920 E 28th Street, Minneapolis, MN 55407, USA
3Kidney Specialists of Minnesota at Abbott Northwestern Hospital, 920 E 28th Street, Minneapolis, MN 55407, USA

Received 9 June 2014; Revised 6 August 2014; Accepted 7 October 2014; Published 19 October 2014

Academic Editor: Shinichi Oikawa

Copyright © 2014 Matthew Lui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Aris P Agouridis, Devaki R Nair, and Dimitri P Mikhailidis, “Strategies to overcome statin intolerance,” Expert Opinion on Drug Metabolism & Toxicology, pp. 1–5, 2015. View at Publisher · View at Google Scholar
  • Marcello Arca, “Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors,” Atherosclerosis, 2016. View at Publisher · View at Google Scholar
  • Patrick M. Moriarty, Klaus G. Parhofer, Stephan P. Babirak, Emil deGoma, P. Barton Duell, Bernd Hohenstein, Wolfgang Ramlow, Vinaya Simha, Elisabeth Steinhagen-Thiessen, Paul D. Thompson, Anja Vogt, Berndt von Stritzky, Yunling Du, and Garen Manvelian, “Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE tr,” Journal Of Clinical Lipidology, vol. 10, no. 3, pp. 627–634, 2016. View at Publisher · View at Google Scholar
  • Thomas Knickelbine, Matthew Lui, Ross Garberich, Michael D. Miedema, Craig Strauss, and Jeffrey J. VanWormer, “Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapies,” Journal of Clinical Lipidology, 2016. View at Publisher · View at Google Scholar
  • Julia Ertl, Klaus G. Parhofer, and Franz-Werner Dippel, “Lipidapherese zur Behandlung der LDL-Hypercholesterinämie in Deutschland,” CardioVasc, vol. 16, no. 5, pp. 51–56, 2016. View at Publisher · View at Google Scholar
  • Thomas Knickelbine, “PCSK9 Inhibitors for Lowering Cholesterol: Ready for Prime Time?,” Journal of the Minneapolis Heart Institute Foundation, vol. 1, no. 1, pp. 30–37, 2017. View at Publisher · View at Google Scholar